# Targeting Leukotrienes in Kidney Disease

> **NCT05362474** · PHASE3 · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 6 (actual)

## Conditions studied

- Diabetic Kidney Disease

## Interventions

- **DRUG:** Montelukast

## Key facts

- **NCT ID:** NCT05362474
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-07-01
- **Primary completion:** 2023-06-20
- **Final completion:** 2023-06-20
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Funding not available
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05362474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05362474, "Targeting Leukotrienes in Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05362474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*